financetom
Business
financetom
/
Business
/
Crewed SpaceX mission delayed after leak in ground equipment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crewed SpaceX mission delayed after leak in ground equipment
Aug 26, 2024 9:36 PM

Aug 27 (Reuters) - The launch of SpaceX's four-person

Polaris Dawn mission will be delayed by at least a day because

of a helium leak in ground equipment at Kennedy Space Center,

the company said on Tuesday, hours before the scheduled liftoff

of its Crew Dragon capsule.

The highlight of the five-day mission is expected to come

two days after launch, when the crew embarks on a 20-minute

spacewalk 434 miles (700 km) from earth, in history's first such

private spacewalk.

The company now aims to launch the spacecraft, carried by a

Falcon 9 booster, at 3:38 a.m. (0738 GMT) on Wednesday, it said

in a posting on X.

"Teams are taking a closer look at a ground-side helium

leak," it added in Tuesday's post. "Falcon and Dragon remain

healthy and the crew continues to be ready for their multi-day

mission to low-Earth orbit."

Only government astronauts have performed spacewalks to

date, most recently by occupants of the International Space

Station, who regularly don spacesuits to perform maintenance and

other checks of their orbital home.

The first U.S. spacewalk was in 1965, aboard a Gemini

capsule, and used a similar procedure to the one planned for

Polaris Dawn: the capsule was depressurised, the hatch opened,

and a spacesuited astronaut ventured outside on a tether.

Polaris Dawn's crew will be testing SpaceX's new, slimline

spacesuits during the spacewalk.

Only two of the four - billionaire Jared Isaacman, mission

pilot Scott Poteet, a retired U.S. Air Force lieutenant colonel,

and SpaceX employees Sarah Gillis and Anna Menon, both senior

engineers at the company - will leave the spacecraft.

Isaacman, the founder of electronic payment company Shift4,

bankrolled the mission; he has declined to say how much he has

spent, but it is estimated to be more than $100 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Envoy Medical Shares Soar 140% Pre-Bell Following FDA Approval of Expanded Acclaim Cochlear Implant Trial
Envoy Medical Shares Soar 140% Pre-Bell Following FDA Approval of Expanded Acclaim Cochlear Implant Trial
Oct 7, 2025
08:36 AM EDT, 10/07/2025 (MT Newswires) -- Envoy Medical ( COCH ) shares soared 140% in Tuesday's premarket session after the company said it was granted US Food and Drug Administration approval to expand a clinical trial of its fully implanted Acclaim cochlear implant to the final stage. The company said the approval, which was based on three-month data from...
Ivanhoe Mines hits record zinc output in Congo's Kipushi mine
Ivanhoe Mines hits record zinc output in Congo's Kipushi mine
Oct 7, 2025
DAKAR, Oct 7 (Reuters) - Ivanhoe Mines ( IVPAF ) produced 71,226 metric tons of copper and a record 57,200 tons of zinc in the third quarter from its flagship Kamoa-Kakula and Kipushi mines in the Democratic Republic of Congo, the company said on Tuesday. The Vancouver-based miner said robust copper output kept it on track to meet full-year production...
GXO Renews Dolce&Gabbana Beauty Logistics Deal, Adds Italian Warehouse
GXO Renews Dolce&Gabbana Beauty Logistics Deal, Adds Italian Warehouse
Oct 7, 2025
08:35 AM EDT, 10/07/2025 (MT Newswires) -- GXO Logistics ( GXO ) said Tuesday that it has renewed a long-term agreement with Dolce&Gabbana Beauty to operate a new dedicated site in Calvenzano, Italy, and handle orders for global distribution, returns, and other services. The roughly 25,000-square-meter facility will manage inbound, stocking, outbound, and value-added work for beauty products, the company...
Jade Biosciences Unveils JADE201 Antibody to Potentially Treat Autoimmune Diseases
Jade Biosciences Unveils JADE201 Antibody to Potentially Treat Autoimmune Diseases
Oct 7, 2025
08:34 AM EDT, 10/07/2025 (MT Newswires) -- Jade Biosciences ( JBIO ) on Tuesday unveiled its JADE201 monoclonal antibody, which it said has the potential to treat a broad range of autoimmune diseases. Jade said it plans to begin a randomized, placebo-controlled study evaluating JADE201 in patients with rheumatoid arthritis in H1 2026. JADE201 is an investigational half-life extended, afucosylated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved